Mercado de análisis de orina: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPHE100001381
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 195
Buy Now

Se prevé que el mercado de análisis de orina alcance los 5.937,97 millones de dólares en 2028 desde los 4.065,79 millones de dólares en 2021; se espera que crezca a una tasa compuesta anual del 5,6% de 2021 a 2028.

Un análisis de orina se utiliza en el diagnóstico y tratamiento de diversos trastornos, como la enfermedad renal. , infecciones del tracto urinario y diabetes. Es el análisis de la orina por medios químicos, físicos y microscópicos para comprobar la presencia de fármacos y entidades relacionadas con enfermedades, incluidas biomoléculas u otros subproductos. El análisis de orina incluye verificar la concentración, apariencia y contenido de la orina. En el análisis de orina, los resultados anormales o las estimaciones fuera del rango esperado pueden indicar una enfermedad o dolencia. Si el resultado del análisis de orina es positivo, puede indicar que los riñones no están funcionando o no filtran la sangre como deberían. También podría ayudar en el diagnóstico de enfermedades cardiovasculares y en la detección del embarazo y la ovulación.

El mercado del análisis de orina se ha segmentado según el producto, el tipo de prueba, la aplicación y el fin. usuario y geografía. Según la geografía, el mercado está segmentado principalmente en América del Norte, Europa, Asia Pacífico, Oriente Medio y África, y América del Sur y Central. El informe ofrece información y un análisis en profundidad del mercado de análisis de orina, enfatizando parámetros como las tendencias del mercado, los avances tecnológicos y la dinámica del mercado, junto con un análisis del panorama competitivo de los principales actores del mercado a nivel mundial.

Perspectivas estratégicas< /h3>

regiones lucrativas para el mercado de análisis de orina


Perspectivas del mercado

Creciente carga del tracto urinario Las infecciones, la diabetes y las enfermedades renales impulsan el crecimiento del mercado de análisis de orina

Según el estudio informado por un grupo de investigadores del Colegio Estadounidense de Médicos y la Sociedad de Enfermedades Infecciosas de América en 2020, ~6 millones de personas en los EE. UU. Visite al médico para el tratamiento de infecciones del tracto urinario (ITU) todos los años. Las mujeres tienen un mayor riesgo de desarrollar infecciones urinarias que los hombres. Según un estudio publicado en la Revista Internacional de Investigación Ambiental y Salud Pública en 2019, los pacientes con enfermedades crónicas existentes, como diabetes mellitus (DM), tienen un mayor riesgo de contraer infecciones urinarias. La demanda de componentes necesarios para el análisis de orina está aumentando debido a la aparición común de diabetes en todo el mundo, ya que la detección primaria de la diabetes implica el análisis de orina. Según la Federación Internacional de Diabetes (FID), ~463 millones de adultos (de 20 a 79 años) en el mundo vivían con diabetes en 2019; Es probable que esta cifra aumente a 700 millones en 2045. Según la FID, ~87,6 millones de adultos de entre 20 y 79 años vivían con diabetes en el Sudeste Asiático en 2019, lo que representa una prevalencia regional del 8,8 %, y ~56,7 % de estos Los casos de diabetes no fueron diagnosticados, lo que demuestra que existe potencial para el desarrollo del mercado del análisis de orina. Además, según un estudio publicado por la Fundación Nacional del Riñón en 2020, ~35,0% de la población diabética mayor de 20 años desarrollaría enfermedades renales crónicas durante ese período. El aumento continuo en la prevalencia del cáncer de próstata y vejiga plantea un fuerte imperativo terapéutico para la implementación de diagnósticos altamente efectivos.

Por lo tanto, la creciente prevalencia de infecciones urinarias, diabetes y enfermedades renales impulsa el crecimiento del mercado de análisis de orina.  

Información basada en el producto

Según el producto, el mercado de análisis de orina se segmenta en consumibles e instrumentos. Se espera que el segmento de consumibles tenga una mayor participación de mercado en 2021 y, además, se prevé que registre una CAGR más alta durante el período de pronóstico.

Análisis de orina Mercado, por producto: 2021 y 2028


Información basada en el tipo de prueba

El mercado de análisis de orina, según el tipo de prueba, se segmenta en pruebas de embarazo y fertilidad, análisis de orina bioquímicos y análisis de sedimentos de orina. El segmento de análisis de orina bioquímico tendría la mayor participación del mercado en 2021 y se estima que registrará la CAGR más alta del mercado durante 2021-2028.

Información basada en aplicaciones

Según la aplicación, el mercado de análisis de orina se segmenta en detección de enfermedades, embarazo y fertilidad. El segmento de detección de enfermedades representaría una mayor participación de mercado en 2021. Se estima que el mercado para el mismo segmento crecerá a una tasa compuesta anual más alta de 2021 a 2028.

Fin Información basada en el usuario

El mercado de análisis de orina, por usuario final, está segmentado en hospitales y clínicas, laboratorios de diagnóstico, entornos de atención domiciliaria y laboratorios e institutos de investigación. El segmento de hospitales y clínicas tendría la mayor participación del mercado en 2021, mientras que se estima que el segmento de laboratorios de diagnóstico registrará la CAGR más alta durante el período de pronóstico.

La COVID-19 ha supuesto la emergencia sanitaria mundial más importante hasta la fecha. Los confinamientos derivados de la pandemia de COVID-19 provocaron que las personas retrasaran la realización de controles de salud, lo que afectó la cantidad de pruebas realizadas y las ventas de instrumentos, consumibles y reactivos. El mercado de análisis de orina experimentó un déficit al comienzo de la crisis de COVID-19 debido a la interrupción en la cadena de suministro y la demanda debido al bloqueo anunciado por la mayoría de los países europeos. Sin embargo, se observa un resurgimiento en el número de pruebas a medida que los países alivian gradualmente las restricciones de movimiento.   

Adquisiciones, colaboraciones, asociaciones, lanzamientos de productos y expansiones. son estrategias comúnmente adoptadas por las empresas para expandir su presencia en todo el mundo y satisfacer la creciente demanda. Los actores del mercado de análisis de orina han estado adoptando principalmente la estrategia de innovación de productos para satisfacer las cambiantes demandas de los clientes en todo el mundo, lo que también les ayuda a mantener su marca a nivel mundial.

Perfiles de la empresa

  • Abbott    
  • ACON Laboratories, Inc.     
  • ARKRAY, Inc. ;                  
  • Beckman Coulter, Inc.       
  • Bio-Rad Laboratories Inc. ;  
  • Cardinal Health Inc ;            
  • F. Hoffmann-La Roche Ltd.
  • Quidel Corporation          
  • Siemens Healthineers AG ;
  • Corporación Sysmex
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the challenges hindering the adoption of Urinalysis?

The factors that are restraining the adoption of urinalysis are stringent regulatory requirements and product recalls.

Who are the major players in the Urinalysis market?

The urinalysis market majorly consists of the players such as players Abbott, ACON Laboratories, Inc., ARKRAY, Inc, Beckman Coulter, Inc., Bio-Rad Laboratories Inc., Cardinal Health Inc., F. Hoffmann-La Roche Ltd., Quidel Corporation, Siemens Healthineers AG, Sysmex Corporation and among others.

What are the driving factors for the urinalysis market across the globe?

The factors that are driving growth of the market are growing burden of urinary tract infection, diabetes, and kidney diseases and rise in prevalence of age-related diseases.

What is urinalysis?

A urinalysis is used in diagnosis and management of range of disorders such as kidney disease, urinary tract infections, and diabetes. In general, urinalysis is a test of urine. Urinalysis is an analysis by chemical, physical, and microscopical means to check for the presence of drugs and disease. A urinalysis includes checking the concentration, appearance, and content of urine. In urinalysis, abnormal results may point to an illness or disease. If the urine test result is positive, it may point that kidneys are not functioning or filtering the blood in the manner as they should. It might also point towards cardiovascular disease. Urinalysis can also be used to detect pregnancy and ovulation.

The List of Companies - Urinalysis Market

  1. Abbott     
  2. ACON Laboratories, Inc.              
  3. ARKRAY, Inc.      
  4. Beckman Coulter, Inc.      
  5. Bio-Rad Laboratories Inc.             
  6. Cardinal Health Inc          
  7. F. Hoffmann-La Roche Ltd.           
  8. Quidel Corporation           
  9. Siemens Healthineers AG            
  10. Sysmex Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports